Format

Send to

Choose Destination
Circ Cardiovasc Qual Outcomes. 2017 Jul;10(7). pii: e000026. doi: 10.1161/HCQ.0000000000000026.

2017 ACC/AAP/AHA Health Policy Statement on Opportunities and Challenges in Pediatric Drug Development: Learning From Sildenafil.

Author information

1
American College of Cardiology Representative. American Heart Association Representative. American Academy of Pediatrics Representative. US Food and Drug Administration Representative. Retired from the US Food and Drug Administration during the development of this statement.

KEYWORDS:

AHA Scientific Statements; US Food and Drug Administration; drug development; pediatric clinical trials; sildenafil

PMID:
28663437
PMCID:
PMC5614492
DOI:
10.1161/HCQ.0000000000000026
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Atypon Icon for PubMed Central
Loading ...
Support Center